Home > Insider Trading > Filing (0001209191-20-056752)

Filing Details

Accession Number:: 0001209191-20-056752
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-03 18:25:05
Reporting Period:: 2020-06-23

Accepted Time:: 2020-11-03 18:25:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1439725	Biodesix Inc	BDSX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1021413	John Patience	2970 Wilderness Place, Suite 100 Boulder CO 80301		Yes	No	Yes	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-10-30	1,829,368	$0.00	1,829,368	No	4	C	Indirect	By Patience Enterprises LP
Common Stock	Acquisiton	2020-10-30	2,501,974	$0.00	2,501,974	No	4	C	Indirect	By John Patience Living Trust dated 7/23/1993
Common Stock	Acquisiton	2020-10-30	245,041	$0.00	2,747,015	No	4	C	Indirect	By John Patience Living Trust dated 7/23/1993
Common Stock	Acquisiton	2020-10-30	81,600	$14.40	1,910,968	No	4	C	Indirect	By Patience Enterprises LP
Common Stock	Acquisiton	2020-10-30	64,416	$14.40	2,811,431	No	4	C	Indirect	By John Patience Living Trust dated 7/23/1993
Common Stock	Acquisiton	2020-10-30	30,000	$18.00	30,000	No	4	P	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Patience Enterprises LP
No	4	C	Indirect	By John Patience Living Trust dated 7/23/1993
No	4	C	Indirect	By John Patience Living Trust dated 7/23/1993
No	4	C	Indirect	By Patience Enterprises LP
No	4	C	Indirect	By John Patience Living Trust dated 7/23/1993
No	4	P	Indirect	By Spouse

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2020-10-30	1,454,545	$0.00	245,042	$0.00
Common Stock	Series B-1 Preferred Stock	Disposition	2020-10-30	1,250,000	$0.00	245,041	$0.00
Common Stock	Series C Preferred Stock	Disposition	2020-10-30	666,666	$0.00	112,311	$0.00
Common Stock	Series D Preferred Stock	Disposition	2020-10-30	250,000	$0.00	42,117	$0.00
Common Stock	Series D Preferred Stock	Disposition	2020-10-30	2,932,534	$0.00	494,033	$0.00
Common Stock	Series E Preferred Stock	Disposition	2020-10-30	809,200	$0.00	136,323	$0.00
Common Stock	Series E Preferred Stock	Disposition	2020-10-30	1,484,624	$0.00	250,109	$0.00
Common Stock	Series F Preferred Stock	Disposition	2020-10-30	3,205,681	$0.00	540,050	$0.00
Common Stock	Series F Preferred Stock	Disposition	2020-10-30	3,055,837	$0.00	514,806	$0.00
Common Stock	Series G Preferred Stock	Disposition	2020-10-30	957,114	$0.00	161,242	$0.00
Common Stock	Series G Preferred Stock	Disposition	2020-10-30	6,711,816	$0.00	1,130,715	$0.00
Common Stock	Series H Preferred Stock	Disposition	2020-10-30	4,182,413	$0.00	704,596	$0.00
Common Stock	3% Convertible Debt due June 2021	Acquisiton	2020-06-23	0	$0.00	10,527	$0.00
Common Stock	3% Convertible Debt due June 2021	Disposition	2020-10-30	0	$0.00	81,600	$14.40
Common Stock	3% Convertible Debt due June 2021	Disposition	2020-10-30	0	$0.00	64,416	$14.40

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
1,150,000	2021-06-30	No	4	A	Indirect
0	2021-06-30	No	4	C	Indirect
0	2021-06-30	No	4	C	Indirect

Footnotes

Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the "Preferred Stock") converted into approximately 0.1684664 shares of Issuer Common Stock ("Common Stock") at the closing of the Issuer's initial public offering ("IPO"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date.
The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The reporting person is the sole trustee of John Patience Trust (July 23, 1993).
Every share of Series B-1 Preferred Stock ("B-1 Preferred Stock") converted into approximately 0.196 shares of Common Stock at the closing of the Issuer's IPO. Share numbers gave effect to such conversion. The B-1 Preferred Stock had no expiration date.
This Convertible Debt paid interest at 3% per annum and was payable in full upon maturity through the conversion to Series H Preferred Stock at 80% of the original issuance price of $1.15 per share. On or before the maturity date and if the Convertible Debt remained unpaid, the outstanding principal and unpaid accrued interest was to be automatically converted into Common Stock at the completion of the IPO at a conversion price equal to 80% of the price per share paid for the Common Stock sold in the IPO. Share numbers give effect to such conversion; debt amount reflects principal only, no interest.
This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.
Upon completion of the IPO, the outstanding principal and unpaid accrued interest on this Convertible Debt was automatically converted into Common Stock. Share numbers gave effect to such conversion; debt amount reflects principal only, no interest.